Ποια είναι η τιμή για Celularity Inc. (CELU)

Η τιμή για Celularity Inc. (CELU) είναι $0.7721

Ποια είναι η κεφαλαιοποίηση αγοράς για Celularity Inc. (CELU)

Η κεφαλαιοποίηση αγοράς για Celularity Inc. (CELU) είναι $22.35M

Celularity Inc. (CELU) Τιμή και Κεφαλαιοποίηση Αγοράς

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.

Η τιμή για CELU	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$183,235 $22.35M	NVDA	$5.304T	+23,731,903.43%
$160,657 $22.35M	AAPL	$4.650T	+20,807,726.32%
$143,555 $22.35M	GOOG	$4.155T	+18,592,653.98%
$124,271 $22.35M	MSFT	$3.597T	+16,095,143.34%
$98,258.04 $22.35M	AMZN	$2.844T	+12,725,976.70%

Η τιμή για CELU

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$183,235 $22.35M